TY - JOUR
T1 - Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1
AU - Wang, Min
AU - Vikis, Haris G.
AU - Wang, Yian
AU - Jia, Dongmei
AU - Wang, Daolong
AU - Bierut, Laura J.
AU - Bailey-Wilson, Joan E.
AU - Amos, Christopher I.
AU - Pinney, Susan M.
AU - Petersen, Gloria M.
AU - De Andrade, Mariza
AU - Yang, Ping
AU - Wiest, Jonathan S.
AU - Fain, Pamela R.
AU - Schwartz, Ann G.
AU - Gazdar, Adi
AU - Minna, John
AU - Gaba, Colette
AU - Rothschild, Henry
AU - Mandal, Diptasri
AU - Kupert, Elena
AU - Seminara, Daniela
AU - Liu, Yan
AU - Viswanathan, Avinash
AU - Govindan, Ramaswamy
AU - Anderson, Marshall W.
AU - You, Ming
PY - 2007/1/1
Y1 - 2007/1/1
N2 - In this study, we observed loss of heterozygosity (LOH) in human chromosomal fragment 6q25.1 in sporadic lung cancer patients. LOH was observed in 65% of the 26 lung tumors examined and was narrowed down to a 2.2-Mb region. Single-nucleotide polymorphism (SNP) analysis of genes located within this region identified a candidate gene, termed p34. This gene, also designated as ZC3H12D, C6orf95, FLJ46041, or dJ281H8.1, carries an A/G nonsynonymous SNP at codon 106, which alters the amino acid from lysine to argmine. Nearly 73% of heterozygous lung cancer tissues with LOH and the A/G SNP also exhibited loss of the A allele. In vitro clonogenic and in vivo nude mouse studies showed that overexpression of the A allele exerts tumor suppressor function compared with the G allele. p34 is located within a recently mapped human lung cancer susceptibility locus, and association of the p34 A/G SNP was tested among these families. No significant association between the less frequent G allele and lung cancer susceptibility was found. Our results suggest that p34 may be a novel tumor suppressor gene involved in sporadic lung cancer but it seems not to be the candidate familial lung cancer susceptibility gene linked to chromosomal region 6q23-25.
AB - In this study, we observed loss of heterozygosity (LOH) in human chromosomal fragment 6q25.1 in sporadic lung cancer patients. LOH was observed in 65% of the 26 lung tumors examined and was narrowed down to a 2.2-Mb region. Single-nucleotide polymorphism (SNP) analysis of genes located within this region identified a candidate gene, termed p34. This gene, also designated as ZC3H12D, C6orf95, FLJ46041, or dJ281H8.1, carries an A/G nonsynonymous SNP at codon 106, which alters the amino acid from lysine to argmine. Nearly 73% of heterozygous lung cancer tissues with LOH and the A/G SNP also exhibited loss of the A allele. In vitro clonogenic and in vivo nude mouse studies showed that overexpression of the A allele exerts tumor suppressor function compared with the G allele. p34 is located within a recently mapped human lung cancer susceptibility locus, and association of the p34 A/G SNP was tested among these families. No significant association between the less frequent G allele and lung cancer susceptibility was found. Our results suggest that p34 may be a novel tumor suppressor gene involved in sporadic lung cancer but it seems not to be the candidate familial lung cancer susceptibility gene linked to chromosomal region 6q23-25.
UR - http://www.scopus.com/inward/record.url?scp=33846408685&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-06-2723
DO - 10.1158/0008-5472.CAN-06-2723
M3 - Article
C2 - 17210687
AN - SCOPUS:33846408685
SN - 0008-5472
VL - 67
SP - 93
EP - 99
JO - Cancer research
JF - Cancer research
IS - 1
ER -